MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years

被引:98
作者
Benton, N
Stewart, N
Crabbe, J
Robinson, E
Yeoman, S
McQueen, FM
机构
[1] Auckland Hosp, Dept Rheumatol, Auckland 1, New Zealand
[2] Auckland Hosp, Dept Radiol, Auckland, New Zealand
[3] Univ Auckland, Auckland Sch Med, Dept Mol Med, Auckland 1, New Zealand
关键词
D O I
10.1136/ard.2003.011544
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine whether magnetic resonance (MR) scans of the dominant wrist of patients with early rheumatoid arthritis (RA) can be used to predict functional outcome at 6 years' follow up. Methods: Dominant wrist MR scans were obtained in 42 patients with criteria for RA at first presentation. Patients were followed up prospectively for 6 years, and further scans obtained at 1 year ( 42 patients) and 6 years ( 31 patients). Two radiologists scored scans for synovitis, tendonitis, bone oedema, and erosions. The Stanford Health Assessment Questionnaire (HAQ) score, indicating functional outcome, and standard measures of disease activity were assessed at 0, 1, 2, and 6 years. The physical function component of the SF-36 score (PF-SF36) was also used as a functional outcome measure at 6 years. Results: Baseline MR parameters, including bone oedema score and the total baseline MR score, were predictive of the PF-SF36 at 6 years (R-2 = 0.22, p = 0.005 and R-2 = 0.16, p = 0.02, respectively). The PF-SF36 score correlated strongly with the HAQ score at 6 years (r(s) = -0.725, p< 0.0001); none of the baseline MR parameters predicted the 6 year HAQ score. The total MR score obtained at 1 year was predictive of the 6 year HAQ (R-2 = 0.04, p = 0.01). Standard clinical and radiographic measures at baseline were not predictive of the 6 year PF-SF36, but when combined in a model with baseline MR oedema score, prediction increased from 0.09 to 0.23, or 23% of the 6 year variance. Conclusion: MR imaging of the wrist in patients with early RA can help to predict function at 6 years and could be used to plan aggressive management at an earlier stage.
引用
收藏
页码:555 / 561
页数:7
相关论文
共 32 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]  
Boutry N, 2003, J RHEUMATOL, V30, P671
[3]   WHICH OUTCOME MEASURES SHOULD BE USED IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS - CLINICAL AND QUALITY-OF-LIFE MEASURES RESPONSIVENESS TO TREATMENT IN A RANDOMIZED CONTROLLED TRIAL [J].
BUCHBINDER, R ;
BOMBARDIER, C ;
YEUNG, M ;
TUGWELL, P .
ARTHRITIS AND RHEUMATISM, 1995, 38 (11) :1568-1580
[4]  
COMBE B, 1995, BRIT J RHEUMATOL, V34, P529
[5]  
CONAGHAN PG, 1999, ANN RHEUM DIS S, V58, P28
[6]   Long term anti-tumour necrosis factor α monotherapy in rheumatoid arthritis:: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation [J].
den Broeder, AA ;
Joosten, LAB ;
Saxne, T ;
Heinegård, D ;
Fenner, H ;
Miltenburg, AMM ;
Frasa, WLH ;
van Tits, LJ ;
Buurman, WA ;
van Riel, PLCM ;
van de Putte, LBA ;
Barrera, P .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (04) :311-318
[7]  
Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO
[8]  
2-F
[9]   PROGNOSIS IN RHEUMATOID-ARTHRITIS - LONGITUDINAL-STUDY OF NEWLY DIAGNOSED YOUNGER ADULT PATIENTS [J].
FEIGENBAUM, SL ;
MASI, AT ;
KAPLAN, SB .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (03) :377-384
[10]  
FOLEYNOLAN D, 1991, BRIT J RHEUMATOL, V30, P101